Author:
Neuzillet Cindy,de Mestier Louis,Rousseau Benoît,Mir Olivier,Hebbar Mohamed,Kocher Hemant M.,Ruszniewski Philippe,Tournigand Christophe
Subject
Pharmacology (medical),Pharmacology
Reference306 articles.
1. Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (alliance);Abou-Alfa;Journal of Clinical Oncology,2016
2. Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: More questions than answers? A review emphasizing the need for a standardized GIST reporting;Agaimy;International Journal of Clinical and Experimental Pathology,2010
3. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours;Agaimy;Journal of Clinical Pathology,2009
4. Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours;Ahn;British Journal of Cancer,2013
5. Impact of previous somatostatin analogue use on the activity of Everolimus in patients with advanced neuroendocrine tumors: Analysis from the phase III RADIANT-2 trial;Anthony;Neuroendocrinology,2015
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献